麻豆传媒

Are in the works for an updated Apple Watch? (Forbes)

Heart attack survivors saw no reduction in cardiovascular death and heart failure using sacubitril/valsartan (Entresto) compared with ramipril, Novartis said. More details on the are to be announced at the American College of Cardiology meeting later this month. (FiercePharma)

Switching to in the emergency department was associated with more findings of myocardial injury and MI, but no overall increase in resource use (except angiography), a health system found in its Wisconsin hospitals. (Journal of the American College of Cardiology)

Meanwhile, Roche to use its cardiac troponin T and N-terminal pro-brain natriuretic peptide tests in identifying a person's cardiovascular risk.

Medication may be considered for low-risk patients with stage 1 hypertension not reaching target blood pressure , the American Heart Association said. (Hypertension)

Guidance on was offered by the Society of Cardiovascular Computed Tomography.

Kaiser Permanente probes the use of artificial intelligence sweeping through electronic health records and echocardiograms to . (FierceHealthcare)

FDA approved the for hybrid ablation in patients with long-standing persistent atrial fibrillation, AtriCure announced.

People with may still be good candidates for antihypertensive medication, a meta-analysis suggested. (The Lancet)

Surgical mitral repair is rarely achieved after a . (Journal of the American College of Cardiology)

Black and Hispanic patients have a lower prevalence of compared with white peers, which may explain their lower utilization of carotid revascularization procedures. (Stroke)

One center found that its COVID patients tended to have heart attacks involving than those without COVID.

Children exposed to certain air pollutants were more likely to experience , a meta-analysis found. (Journal of the American Heart Association)

, carrying information similar to the real thing, are proposed as a solution to privacy issues in big medical datasets. (medRxiv)

A CMS New Technology Add-On Payment has been proposed for with the Shockwave system.

Registry data showed worked in newborns with persistent pulmonary hypertension who had been born preterm, Mallinckrodt said.

The is now under clinical investigation for bleeding management in liver resection surgery, with the manufacturer, GATT Technologies, eyeing uses in heart, lung, and other surgeries in the future.

Proteo-transcriptomic analysis of explanted human hearts revealed that in sinoatrial node dysfunction in heart failure, scientists reported. (Circulation)

Comment